VolitionRx Limited Revenue
VolitionRx Limited (VNRX) reported Revenue of $398.66 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Income Statement
us-gaap:Revenues · last filed 2026-08-13
- VolitionRx Limited revenues for the quarter ending 2026-06-30 was $398.66K, a 1.97% decline year-over-year.
- VolitionRx Limited revenues for the quarter ending 2026-03-31 was $985.08K, a 299.81% increase year-over-year.
- VolitionRx Limited revenues for the quarter ending 2025-12-31 was $447.03K, a 133.25% increase year-over-year.
- VolitionRx Limited revenues for the quarter ending 2025-09-30 was $627.28K, a 32.19% increase year-over-year.
- VolitionRx Limited revenues for fiscal 2025 was $1.73M, a 40.04% increase from fiscal 2024.
- VolitionRx Limited revenues for fiscal 2024 was $1.23M, a 59.10% increase from fiscal 2023.
- VolitionRx Limited revenues for fiscal 2023 was $775.30K, a 153.04% increase from fiscal 2022.
- VolitionRx Limited revenues for fiscal 2022 was $306.39K, a 240.30% increase from fiscal 2021.
| Period end | Revenues 3 month | Revenues 5 month | Revenues 6 month | Revenues 9 month | Revenues 12 month | Revenues 17 month | Revenues 20 month | Revenues 23 month | Revenues 26 month | Revenues 29 month | Revenues 32 month | Revenues 35 month | Revenues 38 month | Revenues 41 month | Revenues 44 month | Revenues 47 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $398.66K 10-Q · filed 2026-08-13 | $1.38M 10-Q · filed 2026-08-13 | $1.83M derived: sum of 3 quarters · filed 2026-08-13 | $2.46M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||
| 2026-03-31 | $985.08K 10-Q · filed 2026-05-14 | $1.43M derived: sum of 2 quarters · filed 2026-05-14 | $2.06M derived: sum of 3 quarters · filed 2026-05-14 | $2.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||
| 2025-12-31 | $447.03K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $1.07M derived: sum of 2 quarters · filed 2026-03-31 | $1.48M derived: sum of 3 quarters · filed 2026-08-13 | $1.73M 10-K · filed 2026-03-31 | ||||||||||||
| 2025-09-30 | $627.28K 10-Q · filed 2025-11-13 | $1.03M derived: sum of 2 quarters · filed 2026-08-13 | $1.28M 10-Q · filed 2025-11-13 | $1.47M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||
| 2025-06-30 | $406.69K 10-Q · filed 2026-08-13 | $653.07K 10-Q · filed 2026-08-13 | $844.73K derived: sum of 3 quarters · filed 2026-08-13 | $1.32M derived: sum of 4 quarters · filed 2026-08-13 | ||||||||||||
| 2025-03-31 | $246.38K 10-Q · filed 2026-05-14 | $438.04K derived: sum of 2 quarters · filed 2026-05-14 | $912.56K derived: sum of 3 quarters · filed 2026-05-14 | $1.31M derived: sum of 4 quarters · filed 2026-05-14 | ||||||||||||
| 2024-12-31 | $191.66K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $666.18K derived: sum of 2 quarters · filed 2026-03-31 | $1.06M derived: sum of 3 quarters · filed 2026-03-31 | $1.23M 10-K · filed 2026-03-31 | ||||||||||||
| 2024-09-30 | $474.52K 10-Q · filed 2025-11-13 | $870.32K derived: sum of 2 quarters · filed 2025-11-13 | $1.04M 10-Q · filed 2025-11-13 | $1.29M derived: sum of 4 quarters · filed 2025-11-13 | ||||||||||||
| 2024-06-30 | $395.80K 10-Q · filed 2025-08-14 | $567.33K 10-Q · filed 2025-08-14 | $811.30K derived: sum of 3 quarters · filed 2025-08-14 | $976.52K derived: sum of 4 quarters · filed 2025-08-14 | ||||||||||||
| 2024-03-31 | $171.53K 10-Q · filed 2025-05-15 | $415.51K derived: sum of 2 quarters · filed 2025-05-15 | $580.72K derived: sum of 3 quarters · filed 2025-05-15 | $797.03K derived: sum of 4 quarters · filed 2025-05-15 | ||||||||||||
| 2023-12-31 | $243.97K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | $409.18K derived: sum of 2 quarters · filed 2025-03-31 | $625.49K derived: sum of 3 quarters · filed 2025-03-31 | $775.30K 10-K · filed 2025-03-31 | ||||||||||||
| 2023-09-30 | $165.21K 10-Q · filed 2024-11-14 | $381.52K derived: sum of 2 quarters · filed 2024-11-14 | $531.33K 10-Q · filed 2024-11-14 | $651.04K derived: sum of 4 quarters · filed 2024-11-14 | ||||||||||||
| 2023-06-30 | $216.31K 10-Q · filed 2024-08-14 | $366.12K 10-Q · filed 2024-08-14 | $485.83K derived: sum of 3 quarters · filed 2024-08-14 | $518.55K derived: sum of 4 quarters · filed 2024-08-14 | ||||||||||||
| 2023-03-31 | $149.81K 10-Q · filed 2024-05-13 | $269.52K derived: sum of 2 quarters · filed 2024-05-13 | $302.24K derived: sum of 3 quarters · filed 2024-05-13 | $341.99K derived: sum of 4 quarters · filed 2024-05-13 | ||||||||||||
| 2022-12-31 | $119.72K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $152.43K derived: sum of 2 quarters · filed 2024-03-25 | $192.18K derived: sum of 3 quarters · filed 2024-03-25 | $306.39K 10-K · filed 2024-03-25 | ||||||||||||
| 2022-09-30 | $32.71K 10-Q · filed 2023-11-14 | $72.47K derived: sum of 2 quarters · filed 2023-11-14 | $186.68K 10-Q · filed 2023-11-14 | $200.92K derived: sum of 4 quarters · filed 2023-11-14 | ||||||||||||
| 2022-06-30 | $39.75K 10-Q · filed 2023-08-14 | $153.96K 10-Q · filed 2023-08-14 | $168.20K derived: sum of 3 quarters · filed 2023-08-14 | $193.69K derived: sum of 4 quarters · filed 2023-08-14 | ||||||||||||
| 2022-03-31 | $114.21K 10-Q · filed 2023-05-10 | $128.45K derived: sum of 2 quarters · filed 2023-05-10 | $153.93K derived: sum of 3 quarters · filed 2023-05-10 | $178.72K derived: sum of 4 quarters · filed 2023-05-10 | ||||||||||||
| 2021-12-31 | $14.24K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-15 | $39.72K derived: sum of 2 quarters · filed 2023-03-15 | $64.50K derived: sum of 3 quarters · filed 2023-03-15 | $90.03K 10-K · filed 2023-03-15 | ||||||||||||
| 2021-09-30 | $25.48K 10-Q · filed 2022-11-14 | $50.27K derived: sum of 2 quarters · filed 2022-11-14 | $75.80K 10-Q · filed 2022-11-14 | $82.92K derived: sum of 4 quarters · filed 2022-11-14 | ||||||||||||
| 2021-06-30 | $24.78K 10-Q · filed 2022-08-10 | $50.31K 10-Q · filed 2022-08-10 | $57.43K derived: sum of 3 quarters · filed 2022-08-10 | $58.01K derived: sum of 4 quarters · filed 2022-08-10 | ||||||||||||
| 2021-03-31 | $25.53K 10-Q · filed 2022-05-11 | $32.65K derived: sum of 2 quarters · filed 2022-05-11 | $33.23K derived: sum of 3 quarters · filed 2022-05-11 | $38.42K derived: sum of 4 quarters · filed 2022-05-11 | ||||||||||||
| 2020-12-31 | $7.12K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $7.70K derived: sum of 2 quarters · filed 2022-03-30 | $12.89K derived: sum of 3 quarters · filed 2022-03-30 | $13.43K 10-K · filed 2022-03-30 | ||||||||||||
| 2020-09-30 | $575.00 10-Q · filed 2021-11-10 | $5.77K derived: sum of 2 quarters · filed 2021-11-10 | $6.31K 10-Q · filed 2021-11-10 | $6.31K derived: sum of 4 quarters · filed 2021-11-10 | ||||||||||||
| 2020-06-30 | $5.19K 10-Q · filed 2021-08-11 | $5.74K 10-Q · filed 2021-08-11 | $5.74K derived: sum of 3 quarters · filed 2021-08-11 | $22.83K derived: sum of 4 quarters · filed 2021-08-11 | ||||||||||||
| 2020-03-31 | $544.00 10-Q · filed 2021-05-11 | $544.00 derived: sum of 2 quarters · filed 2021-05-11 | $17.64K derived: sum of 3 quarters · filed 2021-05-11 | $17.64K derived: sum of 4 quarters · filed 2021-05-11 | ||||||||||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-22 | $17.10K derived: sum of 2 quarters · filed 2021-03-22 | $17.10K derived: sum of 3 quarters · filed 2021-03-22 | $17.10K 10-K · filed 2021-03-22 | ||||||||||||
| 2019-09-30 | $17.10K 10-Q · filed 2020-11-12 | $17.10K derived: sum of 2 quarters · filed 2020-11-12 | $17.10K 10-Q · filed 2020-11-12 | |||||||||||||
| 2019-06-30 | $0.00 10-Q · filed 2020-08-13 | $0.00 10-Q · filed 2020-08-13 | ||||||||||||||
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-18 | $14.79K derived: sum of 2 quarters · filed 2015-11-04 | $14.79K 10-K · filed 2015-03-18 | |||||||||||||
| 2014-09-30 | $14.79K 10-Q · filed 2015-11-04 | $14.79K 10-Q · filed 2015-11-04 | ||||||||||||||
| 2014-06-30 | $54.97K 10-Q · filed 2014-08-01 | |||||||||||||||
| 2014-03-31 | $54.97K 10-Q · filed 2014-05-15 | |||||||||||||||
| 2013-12-31 | $54.97K 10-K · filed 2014-03-28 | |||||||||||||||
| 2013-09-30 | $54.97K 10-Q · filed 2013-10-31 | |||||||||||||||
| 2013-06-30 | $54.97K 10-Q · filed 2013-07-29 | |||||||||||||||
| 2013-03-31 | $54.97K 10-Q · filed 2013-05-06 | |||||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $27.59K derived: sum of 2 quarters · filed 2014-03-28 | $39.30K derived: sum of 3 quarters · filed 2014-03-28 | $54.97K 10-K · filed 2014-03-28 | $54.97K 10-K · filed 2013-04-01 | |||||||||||
| 2012-09-30 | $27.59K 10-Q · filed 2013-10-31 | $39.30K derived: sum of 2 quarters · filed 2013-10-31 | $54.97K 10-Q · filed 2013-10-31 | $54.97K derived: sum of 4 quarters · filed 2013-10-31 | $54.97K 10-Q · filed 2012-11-14 | |||||||||||
| 2012-06-30 | $11.71K 10-Q · filed 2013-07-29 | $27.38K 10-Q · filed 2013-07-29 | $27.38K derived: sum of 3 quarters · filed 2013-07-29 | $27.38K derived: sum of 4 quarters · filed 2013-07-29 | $27.38K 10-Q · filed 2012-08-14 | |||||||||||
| 2012-03-31 | $15.67K 10-Q · filed 2013-05-06 | $15.67K derived: sum of 2 quarters · filed 2013-05-06 | $15.67K derived: sum of 3 quarters · filed 2013-05-06 | $15.67K derived: sum of 4 quarters · filed 2013-05-06 | $15.67K 10-Q · filed 2012-05-15 | |||||||||||
| 2011-12-31 | $0.00 derived: 10-KT/A 12 month − 10-Q 9 month · filed 2012-05-08 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 derived: sum of 3 quarters · filed 2012-11-14 | $0.00 10-KT/A · filed 2012-05-08 | $0.00 10-KT/A · filed 2012-05-08 | |||||||||||
| 2011-09-30 | $0.00 10-Q · filed 2012-11-14 | $0.00 derived: sum of 2 quarters · filed 2012-11-14 | $0.00 10-Q · filed 2012-11-14 | |||||||||||||
| 2011-06-30 | $0.00 10-Q · filed 2012-08-14 | $0.00 10-Q · filed 2012-08-14 | ||||||||||||||
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | $0.00 10-KT/A · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |